SEC FORM 4
$0.00
CORCEPT THERAPEUTICS INC (CORT)
Acquisition (code A) of 138 shares at $0.00 per share.
Reporting Person Mokari Atabak · Officer Title Chief Financial Officer · Transaction Code A
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001193125-26-382463 · filed 2026-09-03 · View filing →